Preferred Label : Anti-CLL-1/Anti-CD38 CAR T Cells;
NCIt synonyms : Anti-CD38/Anti-CLL-1 CAR T Cells; Anti-CLL1/Anti-CD38 CAR T-cells; Anti-CLL1/Anti-CD38 Dual-target CAR-T Cells;
NCIt definition : A preparation of T-lymphocytes that have been genetically modified to express a chimeric
antigen receptor (CAR) specific for the tumor-associated antigens (TAAs) C-type-lectin-like
molecule-1 (CLL-1; CLL1; C-type lectin domain family 12 member A; CLEC12A) and CD38,
with potential immunomodulating and antineoplastic activities. Upon administration,
anti-CLL-1/anti-CD38 CAR T cells specifically and simultaneously target and bind to
CD38- and CLL-1-expressing tumor cells. This induces selective toxicity in CD38- and
CLL-1-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present
on various immune cells and hematologic malignancies, and its expression has been
correlated with poor prognosis. CLL-1, a member of the C-type lectin/C-type lectin-like
domain (CTL/CTLD) superfamily, is overexpressed in leukemic stem cells (LSCs) and
plays an important role in disease progression and relapse for myeloid malignancies.;
Origin ID : C203656;
concept_is_in_subset
- has_target
